Interventions for smokeless tobacco use cessation

Jon Owen Ebbert, Victor Manuel Montori, K. S. Vickers, P. C. Erwin, L. C. Dale, L. F. Stead

Research output: Contribution to journalArticle

40 Citations (Scopus)

Abstract

Background: Use of smokeless tobacco (ST) can lead to nicotine addiction and long-term use can lead to health problems including periodontal disease and cancer. Objectives: To assess the effects of behavioural and pharmacologic interventions for the treatment of ST use. Search strategy: We searched the Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE, EMBASE, CINAHL, Web of Science, PsycINFO, Dissertation Abstracts Online, and Scopus. Date of last search: March, 2007. Selection criteria: Randomized trials of behavioural or pharmacological interventions to help users of ST to quit with follow up of at least six months. Data collection and analysis: Two authors independently extracted data. Main results: Two trials of bupropion SRdid not detect a benefit of treatment at six months or longer (Odds Ratio (OR) 0.86, 95% Confidence Interval (CI): 0.47 to 1.57). Four trials of nicotine patch did not detect a benefit (OR 1.16, 95% CI: 0.88 to 1.54), nor did two trials of nicotine gum (OR 0.98, 95%CI: 0.59 to 1.63). There was statistical heterogeneity among the results of 12 behavioural interventions included in the meta-analyses. Six trials showed significant benefits of intervention. In post-hoc subgroup analyses, behavioural interventions which include telephone counselling or an oral examination may increase abstinence rates more than interventions without these components. Authors' conclusions: Behavioural interventions should be used to help ST users to quit and telephone counselling or an oral examination may increase abstinence rates. Pharmacotherapies have not been shown to affect long-term abstinence.

Original languageEnglish (US)
Article numberCD004306
JournalCochrane Database of Systematic Reviews
Issue number4
DOIs
StatePublished - 2007

Fingerprint

Tobacco Use Cessation
Smokeless Tobacco
Oral Diagnosis
Odds Ratio
Confidence Intervals
Nicotine
Telephone
Counseling
Tobacco Use Cessation Products
Bupropion
Tobacco Use
Periodontal Diseases
MEDLINE
Patient Selection
Meta-Analysis
Pharmacology
Drug Therapy
Health
Therapeutics
Neoplasms

Keywords

  • *Tobacco, smokeless
  • Bupropion [therapeutic use]
  • Chewing gum
  • Counseling
  • Humans
  • Nicotine [therapeutic use]
  • Nicotinic agonists [therapeutic use]
  • Randomized controlled trials as topic
  • Tobacco use cessation [*methods]

ASJC Scopus subject areas

  • Medicine(all)
  • Pharmacology (medical)

Cite this

Interventions for smokeless tobacco use cessation. / Ebbert, Jon Owen; Montori, Victor Manuel; Vickers, K. S.; Erwin, P. C.; Dale, L. C.; Stead, L. F.

In: Cochrane Database of Systematic Reviews, No. 4, CD004306, 2007.

Research output: Contribution to journalArticle

@article{e02f57555b674239ba8c484a35e8ff83,
title = "Interventions for smokeless tobacco use cessation",
abstract = "Background: Use of smokeless tobacco (ST) can lead to nicotine addiction and long-term use can lead to health problems including periodontal disease and cancer. Objectives: To assess the effects of behavioural and pharmacologic interventions for the treatment of ST use. Search strategy: We searched the Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE, EMBASE, CINAHL, Web of Science, PsycINFO, Dissertation Abstracts Online, and Scopus. Date of last search: March, 2007. Selection criteria: Randomized trials of behavioural or pharmacological interventions to help users of ST to quit with follow up of at least six months. Data collection and analysis: Two authors independently extracted data. Main results: Two trials of bupropion SRdid not detect a benefit of treatment at six months or longer (Odds Ratio (OR) 0.86, 95{\%} Confidence Interval (CI): 0.47 to 1.57). Four trials of nicotine patch did not detect a benefit (OR 1.16, 95{\%} CI: 0.88 to 1.54), nor did two trials of nicotine gum (OR 0.98, 95{\%}CI: 0.59 to 1.63). There was statistical heterogeneity among the results of 12 behavioural interventions included in the meta-analyses. Six trials showed significant benefits of intervention. In post-hoc subgroup analyses, behavioural interventions which include telephone counselling or an oral examination may increase abstinence rates more than interventions without these components. Authors' conclusions: Behavioural interventions should be used to help ST users to quit and telephone counselling or an oral examination may increase abstinence rates. Pharmacotherapies have not been shown to affect long-term abstinence.",
keywords = "*Tobacco, smokeless, Bupropion [therapeutic use], Chewing gum, Counseling, Humans, Nicotine [therapeutic use], Nicotinic agonists [therapeutic use], Randomized controlled trials as topic, Tobacco use cessation [*methods]",
author = "Ebbert, {Jon Owen} and Montori, {Victor Manuel} and Vickers, {K. S.} and Erwin, {P. C.} and Dale, {L. C.} and Stead, {L. F.}",
year = "2007",
doi = "10.1002/14651858.CD004306.pub3",
language = "English (US)",
journal = "Cochrane Database of Systematic Reviews",
issn = "1361-6137",
publisher = "John Wiley and Sons Ltd",
number = "4",

}

TY - JOUR

T1 - Interventions for smokeless tobacco use cessation

AU - Ebbert, Jon Owen

AU - Montori, Victor Manuel

AU - Vickers, K. S.

AU - Erwin, P. C.

AU - Dale, L. C.

AU - Stead, L. F.

PY - 2007

Y1 - 2007

N2 - Background: Use of smokeless tobacco (ST) can lead to nicotine addiction and long-term use can lead to health problems including periodontal disease and cancer. Objectives: To assess the effects of behavioural and pharmacologic interventions for the treatment of ST use. Search strategy: We searched the Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE, EMBASE, CINAHL, Web of Science, PsycINFO, Dissertation Abstracts Online, and Scopus. Date of last search: March, 2007. Selection criteria: Randomized trials of behavioural or pharmacological interventions to help users of ST to quit with follow up of at least six months. Data collection and analysis: Two authors independently extracted data. Main results: Two trials of bupropion SRdid not detect a benefit of treatment at six months or longer (Odds Ratio (OR) 0.86, 95% Confidence Interval (CI): 0.47 to 1.57). Four trials of nicotine patch did not detect a benefit (OR 1.16, 95% CI: 0.88 to 1.54), nor did two trials of nicotine gum (OR 0.98, 95%CI: 0.59 to 1.63). There was statistical heterogeneity among the results of 12 behavioural interventions included in the meta-analyses. Six trials showed significant benefits of intervention. In post-hoc subgroup analyses, behavioural interventions which include telephone counselling or an oral examination may increase abstinence rates more than interventions without these components. Authors' conclusions: Behavioural interventions should be used to help ST users to quit and telephone counselling or an oral examination may increase abstinence rates. Pharmacotherapies have not been shown to affect long-term abstinence.

AB - Background: Use of smokeless tobacco (ST) can lead to nicotine addiction and long-term use can lead to health problems including periodontal disease and cancer. Objectives: To assess the effects of behavioural and pharmacologic interventions for the treatment of ST use. Search strategy: We searched the Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE, EMBASE, CINAHL, Web of Science, PsycINFO, Dissertation Abstracts Online, and Scopus. Date of last search: March, 2007. Selection criteria: Randomized trials of behavioural or pharmacological interventions to help users of ST to quit with follow up of at least six months. Data collection and analysis: Two authors independently extracted data. Main results: Two trials of bupropion SRdid not detect a benefit of treatment at six months or longer (Odds Ratio (OR) 0.86, 95% Confidence Interval (CI): 0.47 to 1.57). Four trials of nicotine patch did not detect a benefit (OR 1.16, 95% CI: 0.88 to 1.54), nor did two trials of nicotine gum (OR 0.98, 95%CI: 0.59 to 1.63). There was statistical heterogeneity among the results of 12 behavioural interventions included in the meta-analyses. Six trials showed significant benefits of intervention. In post-hoc subgroup analyses, behavioural interventions which include telephone counselling or an oral examination may increase abstinence rates more than interventions without these components. Authors' conclusions: Behavioural interventions should be used to help ST users to quit and telephone counselling or an oral examination may increase abstinence rates. Pharmacotherapies have not been shown to affect long-term abstinence.

KW - Tobacco, smokeless

KW - Bupropion [therapeutic use]

KW - Chewing gum

KW - Counseling

KW - Humans

KW - Nicotine [therapeutic use]

KW - Nicotinic agonists [therapeutic use]

KW - Randomized controlled trials as topic

KW - Tobacco use cessation [methods]

UR - http://www.scopus.com/inward/record.url?scp=44949130711&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=44949130711&partnerID=8YFLogxK

U2 - 10.1002/14651858.CD004306.pub3

DO - 10.1002/14651858.CD004306.pub3

M3 - Article

C2 - 17943813

AN - SCOPUS:44949130711

JO - Cochrane Database of Systematic Reviews

JF - Cochrane Database of Systematic Reviews

SN - 1361-6137

IS - 4

M1 - CD004306

ER -